Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 192.27%350.42K | -47.70%119.9K | 229.25K | 29,010,700.00%290.11K | -1 | -209.17K | ||||
| Revenue from customers | ---- | --42.29K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | 351.50%350.42K | -66.15%77.61K | --229.25K | ---- | 29,010,700.00%290.11K | ---1 | ---- | ---- | ---209.17K | ---- |
| Cash paid | -3.38%-1.62M | -13.28%-1.57M | 1.16%-1.38M | -56.88%-1.4M | -7.52%-891.29K | 25.97%-828.94K | 26.69%-1.12M | 9.69%-1.53M | -548.36%-1.69M | 7.28%-260.85K |
| Payments to suppliers for goods and services | -3.38%-1.62M | -13.28%-1.57M | 1.16%-1.38M | -56.88%-1.4M | -7.52%-891.29K | 25.97%-828.94K | 26.69%-1.12M | 9.69%-1.53M | -548.36%-1.69M | 7.28%-260.85K |
| Direct interest paid | -143.07%-1.93K | 74.64%-794 | -136.48%-3.13K | 84.92%-1.32K | -71.45%-8.78K | 25.46%-5.12K | 94.59%-6.87K | -1,170.30%-127.03K | ---10K | ---- |
| Direct interest received | 263.68%14.24K | -10.12%3.92K | 1,043.31%4.36K | -92.77%381 | 555.35%5.27K | -88.57%804 | -10.63%7.03K | 90.26%7.87K | 3,660.91%4.14K | -79.05%110 |
| Operating cash flow | 12.95%-1.26M | -25.26%-1.44M | 17.69%-1.15M | -131.40%-1.4M | 27.43%-604.69K | 25.57%-833.25K | 32.01%-1.12M | 13.63%-1.65M | -631.10%-1.91M | 7.14%-260.74K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -335.44%-2.22M | 147.65%944.1K | 63.98%-1.98M | -1,124.89%-5.5M | 83.32%-449.03K | -179.71%-2.69M | 66.32%-962.43K | -3,298.89%-2.86M | -158.24%-84.08K | 351.00%144.38K |
| Capital expenditure reported | -256.09%-2.99M | 57.57%-840.7K | 63.93%-1.98M | -1,244.60%-5.49M | 85.72%-408.53K | -197.22%-2.86M | 58.81%-962.43K | -628.51%-2.34M | -508.13%-320.72K | 22.96%-52.74K |
| Net PPE purchase and sale | ---5.5K | ---- | ---- | ---3.27K | ---- | ---- | ---- | -877.45%-13.26K | ---1.36K | ---- |
| Net business purchase and sale | -119.11%-150K | --784.8K | ---- | ---3.79K | ---- | --168.5K | ---- | ---- | 20.74%238K | --197.12K |
| Net investment purchase and sale | -7.36%926.37K | --1M | ---- | ---- | -124.04%-40.5K | --168.5K | ---- | ---508.12K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -335.44%-2.22M | 147.65%944.1K | 63.98%-1.98M | -1,124.89%-5.5M | 83.32%-449.03K | -179.71%-2.69M | 66.32%-962.43K | -3,298.89%-2.86M | -158.24%-84.08K | 351.00%144.38K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 269.19%3.77M | 27,519.50%1.02M | -100.04%-3.73K | 833.73%9.51M | -65.81%1.02M | 1.09%2.98M | -1.77%2.95M | -22.68%3M | 2,282.14%3.88M | 127.42%162.86K |
| Net issuance payments of debt | ---- | ---11.53K | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-60K | --60K |
| Net common stock issuance | 304.16%3.77M | 25,146.93%934K | -100.04%-3.73K | 833.73%9.51M | --1.02M | ---- | -1.77%2.95M | -23.85%3M | 3,729.96%3.94M | 43.64%102.86K |
| Net other financing activities | ---- | --100K | ---- | ---- | ---- | --2.98M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 269.19%3.77M | 27,519.50%1.02M | -100.04%-3.73K | 833.73%9.51M | -65.81%1.02M | 1.09%2.98M | -1.77%2.95M | -22.68%3M | 2,282.14%3.88M | 127.42%162.86K |
| Net cash flow | ||||||||||
| Beginning cash position | 240.48%728.44K | -93.34%213.95K | 475.48%3.21M | -10.74%557.84K | -46.45%624.97K | 198.07%1.17M | -79.91%391.56K | 2,702.37%1.95M | 180.30%69.53K | -87.78%24.81K |
| Current changes in cash | -43.45%296.33K | 116.71%524K | -220.18%-3.14M | 7,497.15%2.61M | 93.54%-35.29K | -163.17%-546.4K | 157.49%864.95K | -179.64%-1.5M | 3,962.51%1.89M | 126.25%46.51K |
| Effect of exchange rate changes | -124.25%-21.32K | -106.77%-9.51K | 231.63%140.39K | 232.93%42.33K | -851.46%-31.85K | 104.74%4.24K | -70.41%-89.39K | -412.66%-52.46K | -475.15%-10.23K | -67.36%-1.78K |
| End cash Position | 37.75%1M | 240.48%728.44K | -93.34%213.95K | 475.48%3.21M | -10.74%557.84K | -46.45%624.97K | 198.07%1.17M | -79.91%391.56K | 2,702.37%1.95M | 180.30%69.53K |
| Free cash from | -86.35%-4.25M | 27.12%-2.28M | 54.57%-3.13M | -580.56%-6.9M | 72.57%-1.01M | -77.42%-3.69M | 47.90%-2.08M | -79.34%-4M | -610.85%-2.23M | 10.24%-313.48K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |